6550 Reagents Consumables Microbiology Testing Boise VAMC

VA Network Contracting Office 20 in Vancouver, Washington intends to solicit a high-throughput, FDA-approved molecular diagnostic testing system and reagents on behalf of the Boise VA Medical Center, with responses due November 27, 2026, at 5:00 PM Pacific Time. No set-aside is used. The requirement covers a rental purchase agreement for the instrument, plus purchase orders for instrument-specific assays used in rapid syndromic panels for gastrointestinal, respiratory (including COVID-19), meningitis/encephalitis, blood culture, and pneumonia testing. The period of performance runs February 1, 2027 through January 31, 2032, comprising a base year and four one-year options exercisable at the Government's discretion. The line-item attachment lists per-period quantities of 154 blood culture panels, 626 COVID-19 panels, 409 gastrointestinal PCR panels, 16 meningitis/encephalitis panels, and 99 pneumonia BAL PCR panels, each measured in each (EA). The notice assigns NAICS 325413 with a 1,250-employee size standard and PSC 6550.

Respondents must complete sections C through H of the response form, including SAM UEI and tax ID, business size and type, Federal Supply Schedule contract details, and three past contracts for similar services with contract numbers and performance periods. The form also requires yes/no answers on SOW compliance, subcontractor use, and subcontractor licensure. SDVOSB and VOSB respondents must provide VetCert certification and the latest VETS-4212. All prospective contractors must be registered in SAM before any offer. Responses go by email to eric.lingenfelter@va.gov. The notice is a sources sought for market research and planning only and does not constitute a solicitation or commitment to award. Contracting Specialist Eric Lingenfelter is the point of contact at 360-852-9891.